diabetes mellitus, diabetic retinopathy
Conditions
Interventions
skin autofluorescence measurement (non invasive)
Sponsors
University of Groningen
Eligibility
Inclusion criteria
Inclusion criteria: • Willingness to participate. • Age: >18 years. • Patients diagnosed with PDR who have undergone or will undergo vitrectomy at the UMCG. • Patients who have at least 1-year follow-up with BCVA after vitrectomy at the UMCG will be included.
Exclusion criteria
Exclusion criteria: • Unwillingness to participate. • Dark coloured skin (Fitzpatrick type V or VI), which will impair the reliability of the autofluorescence measurement. • Skin abnormalities on both arms that will impair the reliability of the autofluorescence measurement. • Local or general active infection or inflammatory disease. • Known renal disease, current dialysis treatment, or a history of renal transplantation. • Patients with high myopia (>6 diopters), glaucoma, combined retinal disease, prior vitreoretinal surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the relation between skin AF and visual outcome of PDR patients at 1 year after vitrectomy. | — |
Secondary
| Measure | Time frame |
|---|---|
| re-vitrectomy rate within the first year. | — |
Contacts
Public ContactL.I. Los
University Medical Center Groningen
Outcome results
None listed